Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV001694435 | SCV001907985 | benign | not provided | 2019-11-08 | criteria provided, single submitter | clinical testing | |
Fulgent Genetics, |
RCV002496008 | SCV002803558 | likely benign | Genitopatellar syndrome; Blepharophimosis - intellectual disability syndrome, SBBYS type | 2021-07-06 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV002538610 | SCV002997332 | likely benign | Genitopatellar syndrome | 2024-10-12 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV004988708 | SCV005604089 | likely benign | Inborn genetic diseases | 2024-09-11 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Prevention |
RCV004741056 | SCV005353957 | likely benign | KAT6B-related disorder | 2024-07-30 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |